Ospemifene

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 267 publications

A computationally informed framework for lipid-based formulation developability: Integrating predictive models with case studies.

A computationally informed framework for lipid-based formulation developability: Integrating predictive models with case studies.

Journal: Journal of pharmaceutical sciences

Published: December 22, 2025

Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause.

Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause.

Journal: Clinics and practice

Published: December 03, 2025

Treating Genitourinary Syndrome of Menopause in Postmenopausal Women with a History of Breast Cancer.

Treating Genitourinary Syndrome of Menopause in Postmenopausal Women with a History of Breast Cancer.

Journal: Drugs & aging

Published: September 19, 2025

Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies.

Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 15, 2025

Treatment of Menopausal Symptoms When Hormone Therapy Is Contraindicated.

Treatment of Menopausal Symptoms When Hormone Therapy Is Contraindicated.

Journal: Seminars in reproductive medicine

Published: September 02, 2025

Treatment of vulvovaginal atrophy is associated with high levels of satisfaction and improves symptom severity and patient-reported outcomes: 12-month results of the PatieEnt satisfactiON studY (PEONY).

Treatment of vulvovaginal atrophy is associated with high levels of satisfaction and improves symptom severity and patient-reported outcomes: 12-month results of the PatieEnt satisfactiON studY (PEONY).

Journal: Menopause (New York, N.Y.)

Published: August 01, 2025

Ospemifene May Provide Better Results Than Other Approaches to Treat Some Vaginal Symptoms of Menopause.

Ospemifene May Provide Better Results Than Other Approaches to Treat Some Vaginal Symptoms of Menopause.

Journal: American family physician

Published: June 18, 2025

Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis.

Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis.

Journal: The Canadian journal of urology

Published: May 07, 2025

State of the art in menopause: current best practice approaches from the IMS World Congress 2024, Melbourne.

State of the art in menopause: current best practice approaches from the IMS World Congress 2024, Melbourne.

Journal: Climacteric : the journal of the International Menopause Society

Published: February 10, 2025

Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results.

Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results.

Journal: Climacteric : the journal of the International Menopause Society

Published: February 07, 2025

Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY).

Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY).

Journal: Clinical breast cancer

Published: January 29, 2025

Ospemifene, a Selective Estrogen Receptor Modulator, Enhances Oligodendrocyte Myelination and Preserves Neurofunctions Against Injuries.

Ospemifene, a Selective Estrogen Receptor Modulator, Enhances Oligodendrocyte Myelination and Preserves Neurofunctions Against Injuries.

Journal: Journal of neurochemistry

Published: January 11, 2025

Showing 1-12 of 267

Last Updated: 04/28/2026